.png "back to home page")
Editorial: A COVID-19 vaccine doesn't exist yet, but already people don't trust it https://t.co/BOWtDSdvbJ
— L.A. Times Opinion (@latimesopinion) September 18, 2020
Editorial: A COVID-19 vaccine doesn't exist yet, but already people don't trust it https://t.co/vFeTw4wwty (via @latimesopinion)
— Los Angeles Times (@latimes) September 18, 2020
A small victory for #transparency as @moderna_tx and @pfizer share details of #COVID19 #vaccine trials. Next step must be to disclose results to ensure safety and efficacy . There can be no cutting corners when #publichealth is at stake. https://t.co/BFcbIO1AiY
— Health Action Int'l (@HAImedicines) September 18, 2020
Moderna and Pfizer Reveal Secret Blueprints for Coronavirus Vaccine Trials https://t.co/X2a0KDnYIW
— Carlos del Rio (@CarlosdelRio7) September 18, 2020
Why is making the study protocol publicly available not standard for every trial? @peterbachmd @matthewherper
— Mithat Gönen (@gonen_mithat) September 18, 2020
Moderna and Pfizer Reveal Secret Blueprints for Coronavirus Vaccine Trials https://t.co/ERwb3qrqJC
A statistical case can be made for that, but, even if all 32 cases were in the placebo group, that implies only 0.2% in the whole trial (including the vaccine group) were exposed enough to be infected. Seems too low to establish efficacy.
— Max Kennerly (@MaxKennerly) September 18, 2020
More here: https://t.co/qfw4cfhMrr https://t.co/N8KRXBR9v1
Good to see pharmaceutical companies releasing their #COVID19 #vaccine #trial protocols. All others should follow suit & establish new standards of transparency. Not helpful @nytimes to call standard protocols used by every researcher ‘secret blueprints’! https://t.co/dWuRZfmbKY
— Dr Nicole E Basta (@IDEpiPhD) September 18, 2020
Moderna and Pfizer Reveal Secret Blueprints for Coronavirus Vaccine Trials https://t.co/U8LbTIp6tJ
— Senator John Cornyn (@JohnCornyn) September 18, 2020
"The [Moderna] document suggests that the first analysis of the trial data may not be conducted until late December, and that there may not be enough information then to determine whether the vaccine works."https://t.co/pVhafNrON2
— David Dayen (@ddayen) September 17, 2020
Moderna Shares the Blueprint for Its Coronavirus Vaccine Trial https://t.co/pDkS6aPZh8
— Dr. Chris T Pernell (@DrChrisMD) September 17, 2020
The NYT headline wins. OMG THE SECRET BLUEPRINTS ARE REVEALED ? https://t.co/FPnLyWCOjX
— Ed MD (@notdred) September 18, 2020
Nice summary of @moderna_tx's phase 3 #COVID19 protocol (also, hats off for publicly sharing) - sets of expectations & assumptions re: proposed timelines. https://t.co/ODUNo4YQWz
— Pradeep Natarajan (@pnatarajanmd) September 17, 2020
Two drug companies that are leading the race for coronavirus vaccines, Moderna and Pfizer, bow to public pressure, abandoning traditional secrecy to release road maps of how they are evaluating their vaccines, @nytDeniseGrady @katie_thomas report. https://t.co/sY6JSyiHId
— Jennifer Jacobs (@JenniferJJacobs) September 18, 2020
The signifcance of the relase of the @moderna_tx protocol, with its effiacy assumptions and interim analysis plans, and what it tells us, by @nytDeniseGrady and @katie_thomas https://t.co/vjMmCKLULb
— Eric Topol (@EricTopol) September 17, 2020
Some thoughts about this w/r to the primary endpoint (which includes mild infections), the potential of premature stopping at ~53 or 106 events, and that there's no need to rush
— Eric Topol (@EricTopol) September 17, 2020
In https://t.co/vjMmCKLULb by @nytDeniseGrady @katie_thomas
Mixed messages hamstring US #COVID19 responsehttps://t.co/FZruX1tJcm pic.twitter.com/CW0mj8ZKGu
— CIDRAP (@CIDRAP) September 17, 2020
"'The goal of this vaccine — of all vaccines in this case — is to stop the pandemic we all want to get back to a normal life as best we can,' Hoge said."#OperationWarpSpeed https://t.co/6ckpfkBBkw
— Rep. Brad Wenstrup (@RepBradWenstrup) September 18, 2020
ICYMI: Our top takeaways from tonight’s @CBSEveningNews conversation with Moderna president Dr. Stephen Hogehttps://t.co/5S8kycrUHn
— Norah O'Donnell ?? (@NorahODonnell) September 17, 2020
혼합 메시지, 미국 COVID-19 대응 무력화 https://t.co/tg9cDGXZmi
— editoy (@editoy) September 19, 2020
from Moderna, one of the frontrunners: "The document suggests that the first analysis of the trial data may not be conducted until late December, and that there may not be enough information then to determine whether the vaccine works." https://t.co/WuwEuIS2hm
— Virginia Hughes (@virginiahughes) September 17, 2020